Skip to content

A randomized controlled trial comparing acute reconnection rates of pulsed field ablation versus robotically navigated magnetic-guided radiofrequency ablation in pulmonary vein isolation.

A randomized controlled trial comparing acute reconnection rates of pulsed field ablation versus robotically navigated magnetic-guided radiofrequency ablation in pulmonary vein isolation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124884
Enrollment
Unknown
Registered
2026-05-19
Start date
2026-05-31
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal atrial fibrillation

Interventions

Pulsed Field Ablation Group (PFA):Pulsed Field Ablation
Robotically Navigated Magnetic-guided Radiofrequency Ablation Group (RMN-RF group):Robotically Navigated Magnetic-guided Radiofrequency Ablation

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years and <80 years; 2.Diagnosed with paroxysmal atrial fibrillation and meets indications for ablation therapy; 3.Planned to undergo first-time atrial fibrillation ablation procedure; 4.Able to provide written informed consent and willing to comply with all follow-up visits and related examinations.

Exclusion criteria

Exclusion criteria: 1.Contraindications to PFA procedure or anticoagulant medications; 2.Previous atrial fibrillation ablation procedure or cardiac surgery; 3.Occurrence of acute myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, cardiac surgery, or hospitalization for heart failure within 3 months prior to the procedure; 4.Severe renal dysfunction (eGFR <30 ml/min/1.73 m^2) or history of dialysis/renal replacement therapy; 5.Life expectancy <1 year; 6.Pregnant or breastfeeding women; 7.Other conditions deemed by the investigator as unsuitable for participation in this study (e.g., severe liver disease, coagulation disorders, etc.).

Design outcomes

Primary

MeasureTime frame
Proportion of pulmonary vein electrical conduction recovery within 20 minutes post-procedure (calculated per pulmonary vein, for non-inferiority testing);

Secondary

MeasureTime frame
Post-procedure cardiac PET-MRI assessment;1-year treatment success rate (atrial fibrillation/atrial flutter/atrial tachycardia recurrence defined as ECG recording >=10 seconds or Holter monitoring >=30 seconds);Ablation lesion area at 10 and 20 minutes post-procedure in the PFA group;Proportion of pulmonary vein electrical conduction recovery within 20 minutes post-procedure (for superiority analysis);Proportion of pulmonary vein electrical conduction recovery at 0–10 minutes and 10–20 minutes post-procedure;1-year treatment success rate in subjects with versus without acute reconnection;Procedure-related parameters (total procedure time, total operating room time, left atrial dwell time);Incidence of major serious adverse events;

Countries

China

Contacts

Public ContactQI Jin

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

jinqi127@163.com+86 21 64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026